Moxonidine And Rasagiline See Triple-Digit Rises In July
Pricewatch UK – July 2020
Moxonidine led the price rises for established generics in the UK in July, with averages for the hypertension treatment more than doubling in some cases. However, among recently-launched products, rasagiline stood out with an average that was more than three times that of the previous month.
You may also be interested in...
Moxonidine topped our table of Biggest Risers for the second month in a row, as UK prices that had doubled in July accelerated even more rapidly in August.
Shanghai Henlius Biotech has struck a co-development and licensing deal with fellow Chinese firm Essexor biosimilar bevacizumab to treat ophthalmic diseases.
Dr Reddy’s says it has suffered a cyber-attack and has isolated “all data center services” so that it can take actions to mitigate the impact.